Hunan Jingfeng Pharmaceutical Co.,Ltd. (SHE:000908)

SHE:000908 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	21.65	13.17	181.39	172.18	164.2	405.47
Short-Term Investments	-	-	-	-	-	130
Cash & Short-Term Investments	21.65	13.17	181.39	172.18	164.2	535.47
Cash Growth	-87.61%	-92.74%	5.35%	4.86%	-69.34%	0.63%
Accounts Receivable	53.34	85.92	197.02	217.24	465.31	782.46
Other Receivables	47.26	31.95	27.16	91.22	84.43	42.32
Receivables	100.59	117.86	224.18	308.46	549.74	824.78
Inventory	53.39	64.58	120.37	155.4	232.39	326.27
Other Current Assets	26.98	18.15	45.35	41.48	75.55	97.12
Total Current Assets	202.61	213.76	571.3	677.51	1,022	1,784
Property, Plant & Equipment	418.01	434.21	553.48	726.1	1,014	1,232
Long-Term Investments	44.29	44.72	50.46	103.86	166.77	318.78
Goodwill	0.12	0.12	33.03	33.03	71.98	432.69
Other Intangible Assets	55.43	61.55	101.66	100.47	94.62	129.67
Long-Term Deferred Tax Assets	10.33	10.41	30.3	23.57	64.34	57.16
Long-Term Deferred Charges	109.98	107.86	106.49	117.4	253.76	373.32
Other Long-Term Assets	183.34	187.72	10.82	10.36	2.85	22.85
Total Assets	1,024	1,060	1,458	1,792	2,690	4,350
Accounts Payable	106.58	148.94	138.54	122.97	186.25	187.06
Accrued Expenses	111.51	105.76	109.51	63.29	19.1	17.64
Short-Term Debt	194.66	195.82	213.02	475.67	940	1,091
Current Portion of Long-Term Debt	300.96	299.42	299.8	387.68	388.18	76
Current Portion of Leases	-	3.67	3.63	1.3	-	-
Current Income Taxes Payable	31.33	0.62	4.93	1.17	1.25	6.43
Current Unearned Revenue	16.84	24.19	26.2	25.22	22.07	-
Other Current Liabilities	275.21	263.12	287.71	283.8	301.81	294.23
Total Current Liabilities	1,037	1,042	1,083	1,361	1,859	1,672
Long-Term Debt	72.15	72.28	72.52	1	-	389.04
Long-Term Leases	23.62	22.69	9.84	7.87	-	-
Long-Term Unearned Revenue	18.05	20.73	24.81	51.01	124.17	173.17
Long-Term Deferred Tax Liabilities	7.65	7.7	6.45	5.27	8.86	7.97
Other Long-Term Liabilities	125.97	49.08	58.93	38.34	60.14	169.67
Total Liabilities	1,285	1,214	1,256	1,465	2,052	2,412
Common Stock	416.69	416.69	416.69	416.69	416.69	416.69
Additional Paid-In Capital	617.75	617.75	617.75	617.42	647.53	647.53
Retained Earnings	-1,172	-1,065	-850.2	-708.89	-545.23	520.88
Comprehensive Income & Other	-18.52	-18.59	-19.46	-18.83	1.04	0.5
Total Common Equity	-155.74	-49.49	164.79	306.39	520.03	1,586
Minority Interest	-104.66	-104.19	36.85	21.34	118.15	352.2
Shareholders' Equity	-260.4	-153.68	201.63	327.73	638.18	1,938
Total Liabilities & Equity	1,024	1,060	1,458	1,792	2,690	4,350
Total Debt	591.39	593.88	598.81	873.52	1,328	1,556
Net Cash (Debt)	-569.74	-580.72	-417.42	-701.35	-1,164	-1,021
Net Cash Per Share	-0.65	-0.66	-0.47	-0.80	-1.32	-1.16
Filing Date Shares Outstanding	875.63	879.77	879.77	879.77	879.77	879.77
Total Common Shares Outstanding	875.63	879.77	879.77	879.77	879.77	879.77
Working Capital	-834.47	-827.79	-512.06	-683.57	-836.79	111.23
Book Value Per Share	-0.18	-0.06	0.19	0.35	0.59	1.80
Tangible Book Value	-211.29	-111.16	30.1	172.89	353.44	1,023
Tangible Book Value Per Share	-0.24	-0.13	0.03	0.20	0.40	1.16
Buildings	-	337.65	401.86	527.56	677.09	576.22
Machinery	-	291.5	412.21	385.78	570.1	703.48
Construction In Progress	-	70.22	88.37	87.72	82.61	268.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.